Symptomatic male urethral Chlamydia trachomatis infection resulted in inflammation of the prostate, with associated increases in both prostate-specific (PSA) and prostate cancer-specific (PCA3) markers with prostate biopsies showing no evidence of malignancy.
TaylorMLMainousAGIIIWellsBJ. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med2005;37:506–12
2.
SiegelRNaishadhamDJemalA. Cancer statistics, 2012. CA Cancer J Clin2012;62:10–29. doi:10.3322/caac.20138. Epub 2012 Jan 4
3.
SchillingDde ReijkeTTombalBde la TailleAHennenlotterJStenzlA. The prostate cancer gene 3 assay: indications for use in clinical practice. BJU Int2010;105:452–5. Epub 2009 Nov 20
4.
NickelJCShoskesDWangYHow does the pre-massage and postmassage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?J Urol2006;176:119
5.
HeidenreichABellmuntJBollaM, European Association of Urology. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease. Eur Urol2011;59:61–71Epub 2010 Oct 28
6.
SchmittMBravoIGSnijdersPJGissmannLPawlitaMWaterboerT. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol2006;44:504–12
7.
Söderlund-StrandACarlsonJDillnerJ. Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. J Clin Microbiol2009;47:541–6Epub 2009 Jan 14
8.
AnttilaTTenkanenLLummeSChlamydial antibodies and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev2005;14:385–9
